174 related articles for article (PubMed ID: 26014803)
1. Integrated genomic analysis suggests MLL3 is a novel candidate susceptibility gene for familial nasopharyngeal carcinoma.
Sasaki MM; Skol AD; Bao R; Rhodes LV; Chambers R; Vokes EE; Cohen EE; Onel K
Cancer Epidemiol Biomarkers Prev; 2015 Aug; 24(8):1222-8. PubMed ID: 26014803
[TBL] [Abstract][Full Text] [Related]
2. Whole-exome sequencing identifies MST1R as a genetic susceptibility gene in nasopharyngeal carcinoma.
Dai W; Zheng H; Cheung AK; Tang CS; Ko JM; Wong BW; Leong MM; Sham PC; Cheung F; Kwong DL; Ngan RK; Ng WT; Yau CC; Pan J; Peng X; Tung S; Zhang Z; Ji M; Chiang AK; Lee AW; Lee VH; Lam KO; Au KH; Cheng HC; Yiu HH; Lung ML
Proc Natl Acad Sci U S A; 2016 Mar; 113(12):3317-22. PubMed ID: 26951679
[TBL] [Abstract][Full Text] [Related]
3. Whole-Exome Sequencing Study of Familial Nasopharyngeal Carcinoma and Its Implication for Identifying High-Risk Individuals.
Wang TM; He YQ; Xue WQ; Zhang JB; Xia YF; Deng CM; Zhang WL; Xiao RW; Liao Y; Yang DW; Zhou T; Li DH; Luo LT; Tong XT; Wu YX; Chen XY; Li XZ; Zhang PF; Zheng XH; Zhang SD; Hu YZ; Wang F; Wu ZY; Zheng MQ; Huang JW; Jia YJ; Yuan LL; You R; Zhou GQ; Lu LX; Liu YY; Chen MY; Feng L; Dai W; Ren ZF; Mai HQ; Sun Y; Ma J; Zheng W; Lung ML; Jia WH
J Natl Cancer Inst; 2022 Dec; 114(12):1689-1697. PubMed ID: 36066420
[TBL] [Abstract][Full Text] [Related]
4. Quantitation of DNA methylation in Epstein-Barr virus-associated nasopharyngeal carcinoma by bisulfite amplicon sequencing.
Zhao W; Mo Y; Wang S; Midorikawa K; Ma N; Hiraku Y; Oikawa S; Huang G; Zhang Z; Murata M; Takeuchi K
BMC Cancer; 2017 Jul; 17(1):489. PubMed ID: 28716111
[TBL] [Abstract][Full Text] [Related]
5. Identification of genomic alterations in nasopharyngeal carcinoma and nasopharyngeal carcinoma-derived Epstein-Barr virus by whole-genome sequencing.
Tu C; Zeng Z; Qi P; Li X; Guo C; Xiong F; Xiang B; Zhou M; Liao Q; Yu J; Li Y; Li X; Li G; Xiong W
Carcinogenesis; 2018 Dec; 39(12):1517-1528. PubMed ID: 30102338
[TBL] [Abstract][Full Text] [Related]
6. Prevalent somatic BRCA1 mutations shape clinically relevant genomic patterns of nasopharyngeal carcinoma in Southeast Europe.
Fountzilas G; Psyrri A; Giannoulatou E; Tikas I; Manousou K; Rontogianni D; Ciuleanu E; Ciuleanu T; Resiga L; Zaramboukas T; Papadopoulou K; Bobos M; Chrisafi S; Tsolaki E; Markou K; Giotakis E; Koutras A; Psoma E; Kalogera-Fountzila A; Skondra M; Bamia C; Pectasides D; Kotoula V
Int J Cancer; 2018 Jan; 142(1):66-80. PubMed ID: 28857155
[TBL] [Abstract][Full Text] [Related]
7. Genetic and epigenetic landscape of nasopharyngeal carcinoma.
Dai W; Zheng H; Cheung AK; Lung ML
Chin Clin Oncol; 2016 Apr; 5(2):16. PubMed ID: 27121876
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of Rare and Common Variants from Suspected Familial or Sporadic Nasopharyngeal Carcinoma (NPC) Susceptibility Genes in Sporadic NPC.
Liu Z; Goldstein AM; Hsu WL; Yu KJ; Chien YC; Ko JY; Jian JJ; Tsou YA; Leu YS; Liao LJ; Chang YL; Wang CP; Wu JS; Hua CH; Lee JC; Yang TL; Hsiao CK; Wu MS; Tsai MH; Huang KK; Yu K; Jones K; Zhu B; Yeager M; Yu G; Lou PJ; Chen CJ; Hildesheim A;
Cancer Epidemiol Biomarkers Prev; 2019 Oct; 28(10):1682-1686. PubMed ID: 31270100
[TBL] [Abstract][Full Text] [Related]
9. Genetic susceptibility to the endemic form of NPC.
Bei JX; Zuo XY; Liu WS; Guo YM; Zeng YX
Chin Clin Oncol; 2016 Apr; 5(2):15. PubMed ID: 27121875
[TBL] [Abstract][Full Text] [Related]
10. Comprehensive genomic profiling of different subtypes of nasopharyngeal carcinoma reveals similarities and differences to guide targeted therapy.
Ali SM; Yao M; Yao J; Wang J; Cheng Y; Schrock AB; Chirn GW; Chen H; Mu S; Gay L; Elvin JA; Suh J; Miller VA; Stephens PJ; Ross JS; Wang K
Cancer; 2017 Sep; 123(18):3628-3637. PubMed ID: 28581676
[TBL] [Abstract][Full Text] [Related]
11. Constitutive activation of distinct NF-κB signals in EBV-associated nasopharyngeal carcinoma.
Chung GT; Lou WP; Chow C; To KF; Choy KW; Leung AW; Tong CY; Yuen JW; Ko CW; Yip TT; Busson P; Lo KW
J Pathol; 2013 Nov; 231(3):311-22. PubMed ID: 23868181
[TBL] [Abstract][Full Text] [Related]
12. Multigene pathway-based analyses identify nasopharyngeal carcinoma risk associations for cumulative adverse effects of TERT-CLPTM1L and DNA double-strand breaks repair.
Yee Ko JM; Dai W; Wun Wong EH; Kwong D; Tong Ng W; Lee A; Kai Cheong Ngan R; Chung Yau C; Tung S; Li Lung M
Int J Cancer; 2014 Oct; 135(7):1634-45. PubMed ID: 24615621
[TBL] [Abstract][Full Text] [Related]
13. Genome-Wide Analysis of 18 Epstein-Barr Viruses Isolated from Primary Nasopharyngeal Carcinoma Biopsy Specimens.
Tu C; Zeng Z; Qi P; Li X; Yu Z; Guo C; Xiong F; Xiang B; Zhou M; Gong Z; Liao Q; Yu J; He Y; Zhang W; Li X; Li Y; Li G; Xiong W
J Virol; 2017 Sep; 91(17):. PubMed ID: 28637758
[TBL] [Abstract][Full Text] [Related]
14. Epstein-Barr virus infection and nasopharyngeal carcinoma.
Tsao SW; Tsang CM; Lo KW
Philos Trans R Soc Lond B Biol Sci; 2017 Oct; 372(1732):. PubMed ID: 28893937
[TBL] [Abstract][Full Text] [Related]
15. Genomic Analysis of Nasopharyngeal Carcinoma Reveals TME-Based Subtypes.
Zhang L; MacIsaac KD; Zhou T; Huang PY; Xin C; Dobson JR; Yu K; Chiang DY; Fan Y; Pelletier M; Wang Y; Jaeger S; Krishnamurthy Radhakrishnan V; JeBailey L; Skewes-Cox P; Zhang J; Fang W; Huang Y; Zhao H; Zhao Y; Li E; Peng B; Huang A; Dranoff G; Hammerman PS; Engelman J; Bitter H; Zeng YX; Yao Y
Mol Cancer Res; 2017 Dec; 15(12):1722-1732. PubMed ID: 28851814
[TBL] [Abstract][Full Text] [Related]
16. NF-κB Signaling Regulates Expression of Epstein-Barr Virus BART MicroRNAs and Long Noncoding RNAs in Nasopharyngeal Carcinoma.
Verhoeven RJ; Tong S; Zhang G; Zong J; Chen Y; Jin DY; Chen MR; Pan J; Chen H
J Virol; 2016 Jul; 90(14):6475-88. PubMed ID: 27147748
[TBL] [Abstract][Full Text] [Related]
17. EBV Infection and Glucose Metabolism in Nasopharyngeal Carcinoma.
Zhang J; Jia L; Tsang CM; Tsao SW
Adv Exp Med Biol; 2017; 1018():75-90. PubMed ID: 29052133
[TBL] [Abstract][Full Text] [Related]
18. EBV-miR-BART10-3p facilitates epithelial-mesenchymal transition and promotes metastasis of nasopharyngeal carcinoma by targeting BTRC.
Yan Q; Zeng Z; Gong Z; Zhang W; Li X; He B; Song Y; Li Q; Zeng Y; Liao Q; Chen P; Shi L; Fan S; Xiang B; Ma J; Zhou M; Li X; Yang J; Xiong W; Li G
Oncotarget; 2015 Dec; 6(39):41766-82. PubMed ID: 26497204
[TBL] [Abstract][Full Text] [Related]
19. Epstein-Barr virus (EBV) latent membrane protein 1 induces interleukin-8 through the nuclear factor-kappa B signaling pathway in EBV-infected nasopharyngeal carcinoma cell line.
Ren Q; Sato H; Murono S; Furukawa M; Yoshizaki T
Laryngoscope; 2004 May; 114(5):855-9. PubMed ID: 15126743
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of plasma Epstein-Barr virus DNA load to distinguish nasopharyngeal carcinoma patients from healthy high-risk populations in Southern China.
Ji MF; Huang QH; Yu X; Liu Z; Li X; Zhang LF; Wang P; Xie SH; Rao HL; Fang F; Guo X; Liu Q; Hong MH; Ye W; Zeng YX; Cao SM
Cancer; 2014 May; 120(9):1353-60. PubMed ID: 24477877
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
